Page 4 - Patrick Condren News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Residents aim to ‘redress power imbalance’ over character homes We’re sorry, this service is currently unavailable. Please try again later. Dismiss Save Normal text size Advertisement Heritage officers from Queensland’s Environment Department should proactively advise communities which “worthy” character homes facing development assessment could be heritage-listed, residents are suggesting to government. Toowong residents, led by retired Queensland Health deputy director-general John Scott, have put forward a concept where a more proactive Environment Department ...

(1) Cambridge Consultants developed the ground-breaking optics technology powering Ellume's FDA authorized COVID-19 Home Test CAMBRIDGE, United Kingdom and BRISBANE, Australia, March 10, 2021, part of the Capgemini Group. Together, the two companies have developed a next-generation, multi-component reader that combines optics, electronics and software, and powers the core technology behind the Ellume COVID-19 Home Test. Ellume's test is the first rapid self-test for COVID-19 detection granted Emergency Authorization Use by the U.S. FDAfor both asymptomatic and symptomatic use without a pres...

Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test CAMBRIDGE, United Kingdom and BRISBANE, Australia, March 10, 2021 (GLOBE NEWSWIRE) -- Today, digital diagnostics company Ellume highlights the revolutionary technology created in partnership with global product development and technology consultancy firm, Cambridge Consultants, part of the Capgemini Group. Together, the two companies have developed a next-gener...

Aussie-Made Home CCP Virus Test Ramps Up Production for US, Not Australia An Australian-made over-the-counter rapid home test for COVID-19, the disease caused by the CCP virus, will soon be manufactured in the United States to make it available to millions of Americans, but it will not be available to Australians because it is prohibited by law. The company was given an emergency authorisation in December by the U.S. Food and Drug Administration to supply the Ellume COVID-19 Home Test for non-prescription use by symptomatic and asymptomatic individuals aged two years and older. The home t...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Ellume Announces $231.8 Million Agreement with the U.S. Government to Scale Up Production of ... Ellume HealthFebruary 1, 2021 GMT The contract includes the delivery of 8.5 million Ellume COVID-19 Home Tests to support the U.S. Government’s pandemic response The investment will support the establishment of Ellume’s first U.S. manufacturing facility, increasing Ellume’s global production capacity by 500,000+ tests per day once completed; The investment extends Ellume’s engagement with the U.S...